Tomoyuki Shirai Selected Research

Tomoyuki Shirai Research Topics

Disease

57	Neoplasms (Cancer) 09/2014 - 01/2002
51	Carcinogenesis 02/2015 - 01/2002
48	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 01/2002
19	Carcinoma (Carcinomatosis) 12/2013 - 01/2002
16	Adenocarcinoma 02/2015 - 01/2002
11	Hepatocellular Carcinoma (Hepatoma) 10/2013 - 05/2002
10	Neoplasm Metastasis (Metastasis) 11/2013 - 10/2002
6	Adenoma (Adenomas) 10/2013 - 02/2002
6	Aberrant Crypt Foci 01/2011 - 02/2002
6	Body Weight (Weight, Body) 01/2011 - 10/2002
5	Prostatic Intraepithelial Neoplasia 08/2013 - 01/2006
4	Fibrosis (Cirrhosis) 02/2009 - 04/2003
4	Breast Neoplasms (Breast Cancer) 01/2009 - 12/2002
4	Hyperplasia 03/2008 - 01/2002
3	Papilloma (Papillomatosis) 01/2012 - 01/2002
3	Hyperthermia 05/2008 - 09/2005
3	Inflammation (Inflammations) 04/2005 - 04/2003
3	Chronic Pancreatitis 04/2005 - 04/2003
2	Osteolysis 01/2009 - 02/2008
2	Bone Resorption 02/2008 - 01/2006
2	Central Nervous System Neoplasms 10/2007 - 01/2005
2	Atrophy 10/2006 - 04/2005

Drug/Important Bio-Agent (IBA)

17	AndrogensIBA 02/2015 - 06/2002
13	CarcinogensIBA 03/2008 - 10/2002
12	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 08/2013 - 01/2002
11	Proteins (Proteins, Gene)FDA Link 05/2014 - 06/2002
10	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 05/2006
10	benzocycloheptapyridineIBA 08/2013 - 02/2002
9	probasinIBA 11/2009 - 03/2002
9	Messenger RNA (mRNA)IBA 03/2008 - 02/2002
8	Tumor Viral Antigens (Large T Antigen)IBA 11/2009 - 03/2002
7	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 08/2007 - 05/2002
6	Androgen Receptors (Androgen Receptor)IBA 10/2012 - 03/2002
5	Hormones (Hormone)IBA 09/2014 - 02/2003
5	Testosterone (Sustanon)FDA Link 04/2014 - 03/2002
4	AminesIBA 08/2013 - 01/2002
4	N-nitrosomorpholineIBA 08/2007 - 10/2002
4	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 07/2003 - 02/2002
4	Dimenhydrinate (DMH)FDA LinkGeneric 07/2003 - 02/2002
3	DNA AdductsIBA 08/2013 - 05/2003
3	2- amino- 1- methyl- 6- phenolimidazo(4,5- b)pyridine- DNA adductIBA 08/2013 - 04/2002
3	nobiletinIBA 01/2011 - 12/2004
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2009 - 04/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2009 - 04/2005
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2009 - 02/2008
3	Liposomes (Liposome)IBA 05/2008 - 09/2005
3	Drinking WaterIBA 06/2007 - 10/2002
3	IsoflavonesIBA 04/2006 - 12/2002
3	2',3-dimethyl-4-aminobiphenylIBA 01/2005 - 06/2002
3	AntioxidantsIBA 12/2002 - 01/2002
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2015 - 04/2003
2	Caspase 3 (Caspase-3)IBA 02/2015 - 11/2009
2	Ellagic AcidIBA 02/2015 - 01/2013
2	acetovanillone (apocynin)IBA 12/2013 - 11/2013
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2013 - 11/2013
2	Transcription Factors (Transcription Factor)IBA 10/2013 - 02/2005
2	Glutathione PeroxidaseIBA 09/2013 - 12/2007
2	Alkylating AgentsIBA 06/2013 - 05/2006
2	CaspasesIBA 10/2012 - 05/2009
2	candesartanIBA 10/2012 - 04/2005
2	Connexin 43 (Connexin43)IBA 05/2012 - 11/2009
2	Glutathione S-Transferase piIBA 04/2012 - 06/2008
2	kuguacin JIBA 03/2012 - 07/2011
2	Phosphotransferases (Kinase)IBA 10/2010 - 01/2009
2	ConnexinsIBA 02/2010 - 08/2007
2	ResveratrolIBA 11/2009 - 01/2008
2	AntigensIBA 11/2009 - 02/2009
2	Vitamin E FDA LinkGeneric 05/2009 - 01/2001
2	LigandsIBA 01/2009 - 05/2002
2	Small Interfering RNA (siRNA)IBA 06/2008 - 12/2007
2	Androgen Antagonists (Antiandrogens)IBA 06/2008 - 01/2006
2	ButylhydroxybutylnitrosamineIBA 03/2008 - 01/2002
2	Bromodeoxyuridine (BrdU)IBA 03/2008 - 07/2003
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 10/2007 - 01/2005
2	Gap Junction beta-1 ProteinIBA 08/2007 - 01/2005
2	auraptenIBA 04/2007 - 12/2004
2	PhytochemicalsIBA 04/2007 - 12/2004
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2006 - 01/2004
2	Acetates (Acetic Acid Esters)FDA Link 06/2006 - 12/2004
2	Ferrosoferric Oxide (Magnetite)FDA Link 05/2006 - 09/2005
2	Lisinopril (Prinivil)FDA LinkGeneric 04/2005 - 04/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2005 - 04/2003
2	Sodium NitriteIBA 02/2005 - 12/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2005 - 01/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2004 - 10/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2004 - 10/2002
2	Carotenoids (Carotene)IBA 09/2003 - 12/2002
2	Safflower Oil FDA Link 07/2003 - 04/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2003 - 04/2002
2	Conjugated Linoleic AcidsIBA 07/2003 - 04/2002
2	phenethyl isothiocyanate (PEITC)IBA 07/2003 - 03/2003
2	Caffeine (No Doz)FDA LinkGeneric 05/2003 - 01/2002
2	Complementary DNA (cDNA)IBA 02/2003 - 02/2002
2	TeaIBA 12/2002 - 01/2002
2	1-O-hexyl-2,3,5-trimethylhydroquinoneIBA 12/2002 - 02/2002

Therapy/Procedure

14	Therapeutics 09/2014 - 02/2002
10	Chemoprevention 03/2013 - 01/2002
5	Castration 01/2015 - 02/2003
3	Subcutaneous Injections 01/2004 - 12/2002
2	Prostatectomy (Retropubic Prostatectomy) 01/2006 - 01/2002